Eligible patients were HIV-infected adults ( aged @ years ) with HIV-@ RNA of less than @ copies per mL , for at least @ months on triple treatment with lopinavir-ritonavir ( twice daily ) plus lamivudine or emtricitabine and a second nucleos ( t ) ide , with no resistance or virological failure to these drugs , and no positive hepatitis B serum surface antigen .